Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Psychiatry/Psychology | Family Medicine

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 Last 

Alabama

The University of Alabama at Birmingham
Birmingham Alabama 35294

A clinical research study of 100 mg enteric-coated aspirin and Placebo

University of Alabama in Birmingham
Birmingham Alabama 35294

A clinical trial to evaluate treatments using Gantenerumab, Solanezumab, Matching Placebo (Gantenerumab) and Matching Placebo (Solanezumab) for patients with Alzheimers Disease, Dementia or Alzheimers Disease, Familial

Arizona

Phoenix Arizona
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Xenoscience, Inc / 21st Century Neurology
Phoenix Arizona 85004

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

NoesisPharma Clinical Trials
Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Banner Sun Health Research Institute
Sun City Arizona 85351

A clinical research study of [18F]NAV4694 for the treatment of Dementia or Alzheimer's Disease

Tucson Arizona
Updated

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Arkansas

Little Rock Arkansas
Updated

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

California

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD).

View More »

Costa Mesa California
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Costa Mesa California 92627

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

ATP Clinical Research, Inc.
Costa Mesa California 92626

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Culver City California
Updated

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Downey California
Updated

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Downey California 90241

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Diligent Clinical Trials, Inc.
Downey California 90241

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Encino California
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Synergy Escondido
Escondido California 92025

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Southern California Research, LLC
Fountain Valley California 92708

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Glendale California

A clinical research study of ITI-007 and Placebo for the treatment of Alzheimer's Disease

Glendale California
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

University of California San Diego
La Jolla California 92093

A clinical research study of [18F]NAV4694 for the treatment of Dementia or Alzheimer's Disease

University of California, San Diego
La Jolla California 92093-0949

A clinical trial seeking patients for a research study for the treatment of Down Syndrome

Laguna Hills California

A Phase 3 clinical study for patients with Alzheimer's Disease

Feldman, Robert MD
Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Long Beach California
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Collaborative Neuroscience Network
Long Beach California 90806

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Los Alamitos California
Updated

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

Los Angeles California

A Phase 3 clinical study for patients with Alzheimer's Disease

The Shankle Clinic
Newport Beach California 92663

A clinical research study of TRx0237 and Placebo for the treatment of Behavioral Variant Frontotemporal Dementia (bvFTD)

Oceanside California
Updated

A clinical trial to evaluate treatments using Drug: EVP-6124 and Placebo for patients with Alzheimer's Disease or Dementia

University of California, Irvine
Orange California 92868

A clinical trial seeking patients for a research study for the treatment of Down Syndrome

Palo Alto Medical Foundation Research Institute
Palo Alto California 94301

A clinical research study of 100 mg enteric-coated aspirin and Placebo

Neuro-Therapeutics, Inc.
Pasadena California 91105

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Redding California
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Redlands California 92373

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Anderson Clinical Research
Redlands California 92374

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

San Diego California
Updated

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Pacific Research Network
San Diego California 92103

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Memory and Aging Centre
San Francisco California 94158

A clinical research study of TRx0237 and Placebo for the treatment of Behavioral Variant Frontotemporal Dementia (bvFTD)

San Francisco Clinical Research Center
San Francisco California 94118

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Neurological Research Institute
Santa Monica California 90404

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Schuster Medical Research Institute
Sherman Oaks California 91403

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Yorba Linda California 92886

Patients are needed to participate in a clinical research study evaluating Brexpiprazole, OPC-34712 for the treatment of Dementia

Colorado

Mile High Research Center
Denver Colorado 80218

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Connecticut

Coastal Connecticut Research, LLC
New London Connecticut 06320

Parkinson's Disease and Cognition Clinical Research Study

View More »

New Haven Connecticut

A Phase 3 clinical study for patients with Alzheimer's Disease

Institute for Neurodegenerative Disorders
New Haven Connecticut 06510

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Coastal Connecticut Research, LLC
New London Connecticut 06320

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

First 1 2 3 4 5 6 7 8 9 10 11 Last